Hoppenot Herve bought BCYC
January 2, 2026 · Form 4 insider transaction
Hoppenot Herve bought 3,032 shares of Bicycle Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,032
Price
$0.00
Total value
N/A
InsiderHoppenot Herve
RoleDirector
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after15,532
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.; Each RSU represents a contingent right to receive one ordinary share.